# Short Acting Agents Vs Long Acting in Frequent Excerbator COPD Patients

> **NCT05748977** · EARLY_PHASE1 · UNKNOWN · sponsor: **Assiut University** · enrollment: 80 (estimated)

## Conditions studied

- Copd

## Interventions

- **DRUG:** SABA SAMA ICS Vs LABA LAMA ICs

## Key facts

- **NCT ID:** NCT05748977
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-02-20
- **Primary completion:** 2024-02-20
- **Final completion:** 2024-03-20
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2023-03-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05748977

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05748977, "Short Acting Agents Vs Long Acting in Frequent Excerbator COPD Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05748977. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
